Insulet Class Action Lawsuit Filed
Analysis based on 19 articles · First reported Jul 02, 2026 · Last updated Jul 13, 2026
The class action lawsuit against Oracle Corporation and its product recalls have negatively impacted the company's stock price, causing significant drops. This event creates uncertainty for investors in the medical device industry, particularly those holding shares of Oracle Corporation.
Robbins LLP has filed a class action lawsuit against Oracle Corporation on behalf of investors who purchased securities between February 21, 2025, and May 26, 2026. The lawsuit alleges that Oracle Corporation misled investors by failing to disclose defective manufacturing controls and procedures, which led to two voluntary Medical Device Corrections for its Omnipod products in March and May 2026. These corrections, due to manufacturing issues that could result in insulin under-delivery, caused Oracle Corporation's stock price to fall significantly on both occasions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard